Roberto Bellini, Director of Inhibikase Therapeutics IKT, has filed 1 purchase and 0 sales on the open market. The latest trade was on 06/26.

RB

RB

Roberto Bellini

Director

Company

Inhibikase Therapeutics IKT

First filing

24/10/23

Trades

6 trades

Buys / sales

1 / 0

12-month net buying

No record

Last trade

06/26

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Inhibikase TherapeuticsIKT	Open-market buy	24/10/21	24/10/23	1,460,000 sh	$1.37	$2,000,200	No record